沪港深医药ETF招商(517990)利润分配表
| |
2025-12-31 |
2025-06-30 |
2024-12-31 |
2024-06-30 |
| 收入 |
7,363,469.28 |
5,553,741.49 |
-5,816,180.01 |
-6,875,374.67 |
| 利息合计 |
6,966.23 |
3,769.56 |
7,933.69 |
3,438.72 |
| 其中:存款利息收入 |
6,966.23 |
3,769.56 |
7,933.69 |
3,438.72 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
1,308,064.86 |
-701,370.31 |
-4,091,627.85 |
-2,367,859.97 |
| 其中:股票投资收益 |
896,009.55 |
-925,869.08 |
-4,536,130.28 |
-2,610,453.06 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
- |
- |
2,654.02 |
2,654.02 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
412,055.31 |
224,498.77 |
441,848.41 |
239,939.07 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
6,019,407.76 |
6,271,381.54 |
-1,847,625.98 |
-4,522,944.65 |
| 其他收入 |
29,030.43 |
-20,039.30 |
115,140.13 |
11,991.23 |
| 费用 |
252,577.17 |
123,513.03 |
197,855.62 |
156,458.65 |
| 管理人报酬 |
201,654.86 |
94,642.72 |
145,604.49 |
66,473.61 |
| 基金托管费 |
40,330.88 |
18,928.50 |
29,120.94 |
13,294.77 |
| 销售服务费 |
- |
- |
- |
- |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中:卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
10,591.43 |
9,941.81 |
23,130.19 |
76,690.27 |
| 利润总额 |
7,110,892.11 |
5,430,228.46 |
-6,014,035.63 |
-7,031,833.32 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年